Sagespring Wealth Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$926K Sell
4,186
-681
-14% -$167K 0.02% 340
2025
Q4
$1.23M Sell
4,867
-407
-8% -$102K 0.02% 269
2025
Q3
$1.31M Sell
5,274
-45
-0.8% -$10.8K 0.03% 256
2025
Q2
$1.28M Buy
5,319
+64
+1% +$14.9K 0.03% 237
2025
Q1
$1.19M Buy
5,255
+578
+12% +$127K 0.03% 219
2024
Q4
$961K Buy
+4,677
New +$1.03M 0.03% 225

Other funds holding STE

Sagespring Wealth Partners's STE Position: Q1 2026 in Review

Sagespring Wealth Partners reduced its Steris (STE) stake by 14% in Q1 2026, selling an estimated $167K and leaving 4,186 shares worth $926K. The position accounts for 0.02% of the portfolio, ranked #340.

Sagespring Wealth Partners first reported a position in STE in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.31M in Q3 2025. 840 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Sagespring Wealth Partners held 4,186 shares of Steris worth $926K as of Q1 2026.
  • Sagespring Wealth Partners sold 681 Steris shares in Q1 2026, an estimated $167K.
  • Steris made up 0.02% of Sagespring Wealth Partners's portfolio in Q1 2026, its #340 holding.
  • Sagespring Wealth Partners first reported a position in Steris in Q4 2024 and has held it in 6 quarters since.
  • Sagespring Wealth Partners's Steris position peaked at $1.31M in Q3 2025.
  • 840 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.